Published in Prog Neuropsychopharmacol Biol Psychiatry on December 14, 2007
Yokukan-san: a review of the evidence for use of this Kampo herbal formula in dementia and psychiatric conditions. Neuropsychiatr Dis Treat (2014) 0.99
Efficacy and safety of yokukansan in treatment-resistant schizophrenia: a randomized, double-blind, placebo-controlled trial (a Positive and Negative Syndrome Scale, five-factor analysis). Psychopharmacology (Berl) (2014) 0.84
Orengedoku-to augmentation in cases showing partial response to yokukan-san treatment: a case report and literature review of the evidence for use of these Kampo herbal formulae. Neuropsychiatr Dis Treat (2013) 0.83
Yokukansan (TJ-54) for treatment of pervasive developmental disorder not otherwise specified and Asperger's disorder: a 12-week prospective, open-label study. BMC Psychiatry (2012) 0.83
Yi-gan san restores behavioral alterations and a decrease of brain glutathione level in a mouse model of schizophrenia. J Brain Dis (2009) 0.77
Yokukansan and its ingredients as possible treatment options for schizophrenia. Neuropsychiatr Dis Treat (2014) 0.76
Multiple Psychopharmacological Effects of the Traditional Japanese Kampo Medicine Yokukansan, and the Brain Regions it Affects. Front Pharmacol (2017) 0.75
Efficacy and safety of yokukansan in treatment-resistant schizophrenia: a randomized, multicenter, double-blind, placebo-controlled trial. Evid Based Complement Alternat Med (2015) 0.75
A decrease in N-acetylaspartate and an increase in myoinositol in the anterior cingulate gyrus are associated with behavioral and psychological symptoms in Alzheimer's disease. J Neurol Sci (2007) 2.23
Characterization of noncalcified coronary plaques and identification of culprit lesions in patients with acute coronary syndrome by 64-slice computed tomography. JACC Cardiovasc Imaging (2009) 2.20
Prospective versus retrospective ECG-gated 64-detector coronary CT angiography: assessment of image quality, stenosis, and radiation dose. Radiology (2008) 1.65
Possible antipsychotic effects of minocycline in patients with schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry (2006) 1.56
Coronary calcium score as a predictor for coronary artery disease and cardiac events in Japanese high-risk patients. Circ J (2011) 1.53
CSF iron, ferritin and transferrin levels in restless legs syndrome. J Sleep Res (2005) 1.46
Hyperbilirubinemia-related behavioral and neuropathological changes in rats: a possible schizophrenia animal model. Prog Neuropsychopharmacol Biol Psychiatry (2009) 1.44
Accuracy of sonographic elastography in the differential diagnosis of enlarged cervical lymph nodes: comparison with conventional B-mode sonography. AJR Am J Roentgenol (2008) 1.43
Visceral fat accumulation as a predictor of coronary artery calcium as assessed by multislice computed tomography in Japanese patients. Atherosclerosis (2008) 1.42
Primary amenorrhea accompanied by adrenal adenoma: start of menarche soon after tumor resection. Intern Med (2002) 1.37
Efficacy of everolimus with exemestane versus exemestane alone in Asian patients with HER2-negative, hormone-receptor-positive breast cancer in BOLERO-2. Breast Cancer (2013) 1.26
Characterization of the vulnerability to repeated stress in Fischer 344 rats: possible involvement of microRNA-mediated down-regulation of the glucocorticoid receptor. Eur J Neurosci (2008) 1.26
The effects of fixation, processing and evaluation criteria on immunohistochemical detection of hormone receptors in breast cancer. Breast Cancer (2007) 1.20
Expression and mutations of KCNJ5 mRNA in Japanese patients with aldosterone-producing adenomas. J Clin Endocrinol Metab (2012) 1.17
Association between epicardial adipose tissue volume and characteristics of non-calcified plaques assessed by coronary computed tomographic angiography. Int J Cardiol (2011) 1.16
Early death of mice cloned from somatic cells. Nat Genet (2002) 1.15
Association between visceral adipose tissue area and coronary plaque morphology assessed by CT angiography. JACC Cardiovasc Imaging (2010) 1.13
Correlation of L-type amino acid transporter 1 and CD98 expression with triple negative breast cancer prognosis. Cancer Sci (2011) 1.11
Minocycline as adjunctive therapy for schizophrenia: an open-label study. Clin Neuropharmacol (2008) 1.11
Resveratrol acts as an estrogen receptor (ER) agonist in breast cancer cells stably transfected with ER alpha. Int J Cancer (2003) 1.11
Protein expression, gene amplification, and mutational analysis of EGFR in triple-negative breast cancer. Breast Cancer (2012) 1.06
Yi-gan san as adjunctive therapy for treatment-resistant schizophrenia: an open-label study. Clin Neuropharmacol (2009) 1.05
Minocycline as adjunctive therapy for patients with unipolar psychotic depression: an open-label study. Prog Neuropsychopharmacol Biol Psychiatry (2012) 1.04
Two cases of breast cancer with cartilaginous and osseous metaplasia. Breast Cancer (2005) 1.04
Successful treatment of nocturnal eating/drinking syndrome with selective serotonin reuptake inhibitors. Int Clin Psychopharmacol (2003) 0.99
Comprehensive evaluation of noncalcified coronary plaque characteristics detected using 64-slice computed tomography in patients with proven or suspected coronary artery disease. Am Heart J (2007) 0.98
Sleep disturbances and depression in the elderly in Japan. Psychiatry Clin Neurosci (2003) 0.97
Adverse reactions to zolpidem: case reports and a review of the literature. Prim Care Companion J Clin Psychiatry (2010) 0.96
Prevalence of restless legs syndrome in non-institutionalized Japanese elderly. Psychiatry Clin Neurosci (2005) 0.95
Marked improvement in delirium with ramelteon: five case reports. Psychogeriatrics (2012) 0.95
Surgical outcome of stage III and IV adrenocortical carcinoma. Jpn J Clin Oncol (2007) 0.94
Effect of Yi-Gan San on psychiatric symptoms and sleep structure at patients with behavioral and psychological symptoms of dementia. Prog Neuropsychopharmacol Biol Psychiatry (2008) 0.94
Immunohistochemical analysis of 14-3-3 sigma and related proteins in hyperplastic and neoplastic breast lesions, with particular reference to early carcinogenesis. Pathol Int (2004) 0.93
Breath-holding spells in somatoform disorder. Int J Psychiatry Med (2004) 0.92
Yi-gan san for the treatment of borderline personality disorder: an open-label study. Prog Neuropsychopharmacol Biol Psychiatry (2007) 0.92
A feasibility study: evaluation of radiofrequency ablation therapy to hepatocellular carcinoma using image registration of preoperative and postoperative CT. Acad Radiol (2006) 0.91
Improvement in delusions and hallucinations in patients with dementia with Lewy bodies upon administration of yokukansan, a traditional Japanese medicine. Psychogeriatrics (2012) 0.90
Decreased levels of whole blood glial cell line-derived neurotrophic factor (GDNF) in remitted patients with mood disorders. Int J Neuropsychopharmacol (2005) 0.90
Use of multidetector row CT with volume renderings in right lobe living liver transplantation. Eur Radiol (2002) 0.89
Charles Bonnet syndrome: successful treatment of visual hallucinations due to vision loss with Yi-gan san. Prog Neuropsychopharmacol Biol Psychiatry (2008) 0.89
Effect of levothyroxine on prolonged nocturnal sleep time and excessive daytime somnolence in patients with idiopathic hypersomnia. Sleep Med (2011) 0.89
Three-dimensional navigator for retroperitoneal laparoscopic nephrectomy using multidetector row computerized tomography. J Urol (2002) 0.89
Open label trial to evaluate the efficacy and safety of Yokukansan, a traditional Asian medicine, in dementia with Lewy bodies. J Am Geriatr Soc (2011) 0.89
Urinary excretion of biopyrrins, oxidative metabolites of bilirubin, increases in patients with psychiatric disorders. Eur Neuropsychopharmacol (2005) 0.88
The regulatory effect of tamoxifen on fibronectin expression in estrogen-dependent MCF-7 breast carcinoma cells. Oncol Rep (2006) 0.86
Combined presence of aortic valve calcification and mitral annular calcification as a marker of the extent and vulnerable characteristics of coronary artery plaque assessed by 64-multidetector computed tomography. Atherosclerosis (2010) 0.86
Novel class of neural stochastic resonance and error-free information transfer. Phys Rev Lett (2008) 0.86
State-dependent changes in the expression levels of NCAM-140 and L1 in the peripheral blood cells of bipolar disorders, but not in the major depressive disorders. Prog Neuropsychopharmacol Biol Psychiatry (2008) 0.86
Evaluation of autonomic nervous system by salivary alpha-amylase level and heart rate variability in patients with schizophrenia. Eur Arch Psychiatry Clin Neurosci (2013) 0.86
Analysis of complete response by MRI following neoadjuvant chemotherapy predicts pathological tumor responses differently for molecular subtypes of breast cancer. Oncol Lett (2012) 0.85
Triple-negative breast cancer: histological subtypes and immunohistochemical and clinicopathological features. Cancer Sci (2011) 0.85
Survey of aorta and coronary arteries with prospective ECG-triggered 100-kV 64-MDCT angiography. AJR Am J Roentgenol (2009) 0.85
Factors disturbing treatment for cancer in patients with schizophrenia. Psychiatry Clin Neurosci (2006) 0.85
Optimal cardiac phase for coronary artery calcium scoring on single-source 64-MDCT scanner: least interscan variability and least motion artifacts. AJR Am J Roentgenol (2008) 0.84
NREM sleep stage transitions control ultradian REM sleep rhythm. Sleep (2011) 0.84
Efficacy and safety of yokukansan in treatment-resistant schizophrenia: a randomized, double-blind, placebo-controlled trial (a Positive and Negative Syndrome Scale, five-factor analysis). Psychopharmacology (Berl) (2014) 0.84
Effect of risperidone on sleep in schizophrenia: a comparison with haloperidol. Psychiatry Res (2002) 0.84
Effects of donepezil on Alzheimer's disease: the relationship between cognitive function and rapid eye movement sleep. Psychiatry Clin Neurosci (2004) 0.84
Increased expression of splicing factor SRp20 mRNA in bipolar disorder patients. J Affect Disord (2008) 0.84
Combined liver and inferior vena cava resection for adrenocortical carcinoma. Surg Today (2007) 0.84
Yi-gan san for treatment of charles bonnet syndrome (visual hallucination due to vision loss): an open-label study. Clin Neuropharmacol (2011) 0.84
Successful treatment with Yi-Gan San for psychosis and sleep disturbance in a patient with dementia with Lewy bodies. Prog Neuropsychopharmacol Biol Psychiatry (2007) 0.83
Yokukansan (TJ-54) for treatment of pervasive developmental disorder not otherwise specified and Asperger's disorder: a 12-week prospective, open-label study. BMC Psychiatry (2012) 0.83